Aegerion Pharmaceuticals
Aegerion Pharmaceuticals completes $22.5M Series A round financing
Published in Medical Device Business Week, July 12th, 2006
Led by Advent International, the financing included participation by Index Ventures, Alta Partners, and MVM Life Science Partners. The capital is supporting further development of its lead compounds that have been shown to significantly reduce LDL cholesterol.
"Cardiovascular disease (CVD) is the number one killer of Americans, and more than 71 million people in the United States suffer from one or more forms of CVD. There remains a significant unmet clinical need in dyslipidemia, in particular for compounds that further reduce LDL, or 'bad' cholesterol,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Alfacell
Alfacell reports loss of $0.04 per share - Amarin
Amarin announces intention to list on AIM and IEX markets - Axonyx
Axonyx, TorreyPines Therapeutics sign merger agreement - BiPar Sciences
BiPar Sciences accelerates clinical program with new financing - Cangene
Cangene reports $28.7 million in revenues - Cardiome Pharma
Cardiome appoints Sikorsky as chief financial officer - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
